Haematology

Haematology
2022-06-16T00:00:00.000+08:00
Ongoing

MK-1026

MK-1026
Haematology

A Phase 2/3 Relapsed and/or Refractory Multiple Myeloma study

A Phase 2/3 Relapsed and/or Refractory Multiple Myeloma study

Trial overview

Disease

Haematology

Topic

MK-1026

Sponsor

MSD

Description

A Phase 2/3, Randomized, Open-Label Study Comparing Oral Ixazomib/Dexamethasone and Oral Pomalidomide/Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

Study details

For detailed information on this trial, please click here.

Trial status

Recruiting

Location

Oxford :::
Windsor :::

Priniciple Investigator

Dr Jaimal Kothari

MA, BM BCh, MRCP, FRCPath

Haematologist

Oxford +1